Blog

Please note most of these publications were published by our predecessor company CellPoint, LLC.

Theranostics

Cell>Point plans to expedite research program on 99mTc-EC-Amifostine and 177Lu-EC- Amifostine as a potentially effective theranostic technology for COVID-19

CENTENNIAL, Colorado, March 24, 2020 – Cell>Point announced today its plans to move forward with its research program…

Read